Counterfeit products are no longer restricted to Gucci purses and Rolex watches. The pharmaceutical sector has seen an alarming rise in the number of counterfeit products entering traditional distribution and supply chains. As a result, consumers unknowingly purchase counterfeit pharmaceuticals from their local pharmacy and receive little or no therapeutic benefit, or worse, die as a result of ingesting the counterfeited product.
Read the complete article by clicking on the link below.
Author(s)
Related Insights
June 20, 2025
Foley Career Perspectives
Foley Juneteenth Program: Exploring the Hidden History to Further Our Mutual Understanding
In celebration of Juneteenth, Foley & Lardner welcomed Dr. Deirdre Cooper Owens, author and historian, for a firmwide virtual program on…
July 10, 2025
Events
Mandatory Roth Catch-up
Join Foley’s upcoming webinar on mandatory Roth catch-up contributions effective January 1, 2026. Learn how the new rules impact high earners, what guidance exists, and practical tips for plan compliance.
June 20, 2025
Foley Viewpoints
Federal Court Enjoins Former Franchisees and Two Related Entities from Competing Against Franchisor
A federal court recently granted in part and denied in part a franchisor’s motion to enjoin the post-termination activities of its former…